{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:36:53Z","timestamp":1793039813119,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,8,11]],"date-time":"2027-08-11T00:00:00Z","timestamp":1817942400000},"content-version":"am","delay-in-days":314,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["R33AI179929"],"award-info":[{"award-number":["R33AI179929"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI134818"],"award-info":[{"award-number":["R01AI134818"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI150255"],"award-info":[{"award-number":["R01AI150255"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI110762"],"award-info":[{"award-number":["R01AI110762"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.antiviral.2026.106508","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T23:30:50Z","timestamp":1786145450000},"page":"106508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of a cell-based nanoluciferase reporter system for high-throughput screening of HBV cccDNA inhibitors"],"prefix":"10.1016","volume":"254","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7447-8360","authenticated-orcid":false,"given":"Hu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L.","family":"Vollmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6313-1399","authenticated-orcid":false,"given":"Cheng-Der","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Schurdak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6846-9292","authenticated-orcid":false,"given":"Andreas","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7146-916X","authenticated-orcid":false,"given":"Haitao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2026.106508_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2022-328380","article-title":"Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure","author":"Allweiss","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2026.106508_bib2","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/hep.29509","article-title":"A research agenda for curing chronic hepatitis B virus infection","volume":"67","author":"Alter","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2026.106508_bib3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/1087057109335327","article-title":"Stability through the ages: the GSK experience","volume":"14","author":"Blaxill","year":"2009","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.antiviral.2026.106508_bib4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cld.2007.08.002","article-title":"Molecular virology of hepatitis B virus for clinicians","volume":"11","author":"Block","year":"2007","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.antiviral.2026.106508_bib5","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1128\/AAC.00473-12","article-title":"Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation","volume":"56","author":"Cai","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106508_bib6","first-page":"151","article-title":"A southern blot assay for detection of hepatitis B virus covalently closed circular DNA from cell cultures","volume":"1030","author":"Cai","year":"2013"},{"key":"10.1016\/j.antiviral.2026.106508_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.antiviral.2016.05.005","article-title":"Establishment of an inducible HBV stable cell line that expresses cccDNA-dependent epitope-tagged HBeAg for screening of cccDNA modulators","volume":"132","author":"Cai","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106508_bib8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1021\/acschembio.5b00753","article-title":"NanoLuc complementation reporter optimized for accurate measurement of protein interactions in cells","volume":"11","author":"Dixon","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.antiviral.2026.106508_bib9","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1021\/acs.bioconjchem.6b00112","article-title":"NanoLuc: a small luciferase is brightening up the field of bioluminescence","volume":"27","author":"England","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.antiviral.2026.106508_bib10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.antiviral.2007.06.014","article-title":"The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging","volume":"76","author":"Feld","year":"2007","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106508_bib11","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1083\/jcb.106.4.1093","article-title":"Targeting of the hepatitis B virus precore protein to the endoplasmic reticulum membrane: after signal peptide cleavage translocation can be aborted and the product released into the cytoplasm","volume":"106","author":"Garcia","year":"1988","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.antiviral.2026.106508_bib12","doi-asserted-by":"crossref","first-page":"12472","DOI":"10.1128\/JVI.01123-07","article-title":"Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation","volume":"81","author":"Guo","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106508_bib13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1128\/JVI.01921-09","article-title":"Production and function of the cytoplasmic deproteinized relaxed circular DNA of hepadnaviruses","volume":"84","author":"Guo","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106508_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2015.08.005","article-title":"Metabolism and function of hepatitis B virus cccDNA: implications for the development of cccDNA-targeting antiviral therapeutics","volume":"122","author":"Guo","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106508_bib15","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1021\/cb3002478","article-title":"Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate","volume":"7","author":"Hall","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.antiviral.2026.106508_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03501-22","article-title":"Characterization of intracellular precore-derived proteins and their functions in hepatitis B virus-infected human hepatocytes","author":"Hong","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2026.106508_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01695-20","article-title":"Characterization of hepatitis B Precore\/core-related antigens","volume":"95","author":"Hong","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106508_bib18","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.gastro.2018.06.093","article-title":"Cell and animal models for studying hepatitis B virus infection and drug development","volume":"156","author":"Hu","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2026.106508_bib19","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021386","article-title":"Hepadnavirus genome replication and persistence","volume":"5","author":"Hu","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.antiviral.2026.106508_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0014-5793(00)01963-3","article-title":"Secretional luciferase of the luminous shrimp oplophorus gracilirostris: cDNA cloning of a novel imidazopyrazinone luciferase(1)","volume":"481","author":"Inouye","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.antiviral.2026.106508_bib21","series-title":"Assay Guidance Manual, Bethesda (MD)","article-title":"HTS Assay Validation","author":"Iversen","year":"2004"},{"key":"10.1016\/j.antiviral.2026.106508_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11046","article-title":"Versatile protein tagging in cells with split fluorescent protein","volume":"7","author":"Kamiyama","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2026.106508_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010576","article-title":"Hepatitis B virus X protein counteracts high mobility group box 1 protein-mediated epigenetic silencing of covalently closed circular DNA","volume":"18","author":"Kim","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2026.106508_bib24","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1128\/AAC.41.8.1715","article-title":"Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication","volume":"41","author":"Ladner","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106508_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1359-6446(05)03730-X","article-title":"Defining and maintaining a high quality screening collection: the GSK experience","volume":"11","author":"Lane","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.antiviral.2026.106508_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2016.08.026","article-title":"Identification of hydrolyzable tannins (punicalagin, punicalin and geraniin) as novel inhibitors of hepatitis B virus covalently closed circular DNA","volume":"134","author":"Liu","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106508_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006784","article-title":"The role of host DNA ligases in hepadnavirus covalently closed circular DNA formation","volume":"13","author":"Long","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2026.106508_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00539-17","article-title":"Identification of an intermediate in hepatitis B virus covalently closed circular (CCC) DNA formation and sensitive and selective CCC DNA detection","volume":"91","author":"Luo","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106508_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00082-18","article-title":"Preclinical profile of AB-423, an inhibitor of hepatitis B virus pregenomic RNA encapsidation","volume":"62","author":"Mani","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106508_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00444-21","article-title":"RNA helicase DDX17 inhibits hepatitis B virus replication by blocking viral pregenomic RNA encapsidation","volume":"95","author":"Mao","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106508_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbrc.2014.12.082","article-title":"The smallest natural high-active luciferase: cloning and characterization of novel 16.5-kDa luciferase from copepod Metridia longa","volume":"457","author":"Markova","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2026.106508_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00196-19","article-title":"Hepatitis B virus precore protein p22 inhibits alpha interferon signaling by blocking STAT nuclear translocation","volume":"93","author":"Mitra","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106508_bib33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.virusres.2007.12.024","article-title":"Hepatitis B viruses: reverse transcription a different way","volume":"134","author":"Nassal","year":"2008","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2026.106508_bib34","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B","volume":"64","author":"Nassal","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2026.106508_bib35","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","article-title":"Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes","volume":"146","author":"Ni","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2026.106508_bib36","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1111\/j.1440-1746.1997.tb00499.x","article-title":"Molecular biology of hepatitis B virus e antigen","volume":"12","author":"Ou","year":"1997","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2026.106508_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013581","article-title":"HBV p22-interacting protein C1QBP inhibits viral replication through impeding nucleocapsid formation and nuclear import","volume":"21","author":"Peng","year":"2025","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2026.106508_bib38","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1016\/S0960-894X(00)00544-8","article-title":"Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication","volume":"10","author":"Perni","year":"2000","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.antiviral.2026.106508_bib39","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3202","article-title":"Quantification of hepatitis B virus covalently closed circular DNA in infected cell culture models by quantitative PCR","volume":"9","author":"Qu","year":"2019","journal-title":"Bio Protoc"},{"key":"10.1016\/j.antiviral.2026.106508_bib40","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2468-1253(19)30119-0","article-title":"A global scientific strategy to cure hepatitis B","volume":"4","author":"Revill","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2026.106508_bib41","doi-asserted-by":"crossref","first-page":"8953","DOI":"10.1038\/s41598-020-65832-1","article-title":"A simple and scalable strategy for analysis of endogenous protein dynamics","volume":"10","author":"Schwinn","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2026.106508_bib42","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection","volume":"479\u2013480","author":"Seeger","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2026.106508_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00760-23","article-title":"Conditional replication and secretion of hepatitis B virus genome uncover the truncated 3' terminus of encapsidated viral pregenomic RNA","volume":"97","author":"Shen","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106508_bib44","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3851\/IMP2152","article-title":"In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations","volume":"17","author":"Wang","year":"2012","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2026.106508_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/v13081503","article-title":"Rapid and robust continuous purification of high-titer hepatitis B virus for in vitro and in vivo applications","volume":"13","author":"Wettengel","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2026.106508_bib46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0166-3542(95)00042-K","article-title":"Phosphatidyl-2',3'-dideoxy-3'-thiacytidine: synthesis and antiviral activity in hepatitis B-and HIV-1-infected cells","volume":"28","author":"Xie","year":"1995","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106508_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-4939-6700-1_15","article-title":"Detection of hepatitis B virus particles released from cultured cells by particle gel assay","volume":"1540","author":"Yan","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2026.106508_bib48","article-title":"Spinoculation enhances HBV infection in NTCP-reconstituted hepatocytes","volume":"10","author":"Yan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2026.106508_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105552","article-title":"Screening of an epigenetic compound library identifies BRD4 as a potential antiviral target for hepatitis B virus covalently closed circular DNA transcription","volume":"211","author":"Yu","year":"2023","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106508_bib50","article-title":"Host 3' flap endonuclease Mus81 plays a critical role in trimming the terminal redundancy of hepatitis B virus relaxed circular DNA during covalently closed circular DNA formation","volume":"21","author":"Zhang","year":"2025","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2026.106508_bib51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.antiviral.2026.106508_bib52","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.antiviral.2006.05.006","article-title":"Hepatitis B virus e antigen production is dependent upon covalently closed circular (ccc) DNA in HepAD38 cell cultures and may serve as a cccDNA surrogate in antiviral screening assays","volume":"72","author":"Zhou","year":"2006","journal-title":"Antivir. Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354226001671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354226001671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:43:32Z","timestamp":1793036612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354226001671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":52,"alternative-id":["S0166354226001671"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2026.106508","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a cell-based nanoluciferase reporter system for high-throughput screening of HBV cccDNA inhibitors","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2026.106508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106508"}}